Back to Search Start Over

Cholesterolomics: An update.

Authors :
Griffiths WJ
Abdel-Khalik J
Yutuc E
Morgan AH
Gilmore I
Hearn T
Wang Y
Source :
Analytical biochemistry [Anal Biochem] 2017 May 01; Vol. 524, pp. 56-67. Date of Electronic Publication: 2017 Jan 10.
Publication Year :
2017

Abstract

Cholesterolomics can be regarded as the identification and quantification of cholesterol, its precursors post squalene, and metabolites of cholesterol and of its precursors, in a biological sample. These molecules include 1,25-dihydroxyvitamin D <subscript>3</subscript> , steroid hormones and bile acids and intermediates in their respective biosynthetic pathways. In this short article we will concentrate our attention on intermediates in bile acid biosynthesis pathways, in particular oxysterols and cholestenoic acids. These molecular classes are implicated in the aetiology of a diverse array of diseases including autoimmune disease, Parkinson's disease, motor neuron disease, breast cancer, the lysosomal storage disease Niemann-Pick type C and the autosomal recessive disorder Smith-Lemli-Opitz syndrome. Mass spectrometry (MS) is the dominant technology for sterol analysis including both gas-chromatography (GC)-MS and liquid chromatography (LC)-MS and more recently matrix-assisted laser desorption/ionisation (MALDI)-MS for tissue imaging studies. Here we will discuss exciting biological findings and recent analytical improvements.<br /> (Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1096-0309
Volume :
524
Database :
MEDLINE
Journal :
Analytical biochemistry
Publication Type :
Academic Journal
Accession number :
28087213
Full Text :
https://doi.org/10.1016/j.ab.2017.01.009